Chirag K. Patel Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Chirag K. Patel is President & Co-CEO of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 857,980 shares of AMRX, which is worth approximately $7.17 Million. The most recent transaction as insider was on Mar 04, 2025, when has been sold 47,361 shares (Class A Common Stock) at a price of $8.84 per share, resulting in proceeds of $418,671. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 858K

67.39% 3M change

67.39% 12M change

Total Value Held $7.17 Million

Chirag K. Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 04 2025	SELL Payment of exercise price or tax liability	$418,671 $8.84 p/Share	47,361 Reduced 5.23%	857,980 Class A Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	92,592 Added 9.28%	905,341 Class A Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$2,448,656 $8.76 p/Share	279,527 Reduced 25.59%	812,749 Class A Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	-	579,710 Added 34.67%	1,092,276 Class A Common Stock
Dec 16 2021	BUY Open market or private purchase	$212,500 $4.25 p/Share	50,000 Added 8.89%	512,566 Class A Common Stock
Dec 15 2021	BUY Open market or private purchase	$413,000 $4.13 p/Share	100,000 Added 17.78%	462,566 Class A Common Stock

CKP

Chirag K. Patel

President & Co-CEO

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account